| CAS登錄號 | 中文名 | 英文名 | 分子結(jié)構(gòu)式 | 分子式 | 詳情 | 供應(yīng)商 |
| 153-00-4 | 美替諾龍; 17beta-羥基-1-甲基-5ALPHA-雄甾-1-烯-3-酮 | Metenolone; 17beta-Hydroxy-1-METHYL-5ALPHA-androst-1-en-3-one; Methenolone |  | C20H30O2 | 詳情 | 供應(yīng)商 |
| 434-05-9 | 美替諾龍醋酸酯 | Methenolone acetate; 17b-Hydroxy-1-METHYL-5ALPHA-androst-1-en-3-one acetate |  | C22H32O3 | 詳情 | 供應(yīng)商 |
| 641-82-7 | 17beta-甲基-5ALPHA-雄甾烷-3ALPHA,17beta-二醇 | 17b-METHYL-5a-androstane-3a,17b-diol; 17-METHYL-5ALPHA-androstan-3ALPHA,17beta-diol; 17ALPHA-METHYL-5ALPHA-androstan-3ALPHA,17beta-diol |  | C20H34O2 | 詳情 | 供應(yīng)商 |
| 1424-00-6 | 甲氫睪酮; 17beta-羥基-1ALPHA-甲基-5ALPHA-雄甾烷-3-酮 | Mesterolone; 17beta-Hydroxy-1ALPHA-METHYL-5ALPHA-androstan-3-one; 1ALPHA-Methylandrostan-17beta-ol-3-one |  | C20H32O2 | 詳情 | 供應(yīng)商 |
| 3366-95-8 | 塞克硝唑; 1-(2-羥基丙基)-2-甲基-5-硝基咪唑 | Secnidazole; ALPHA,2-DiMETHYL-5-nitro-1H-imidazole-1-ethanol |  | C7H11N3O3 | 詳情 | 供應(yīng)商 |
| 10418-03-8 | 康力龍 | Stanozolol; Androstanazol; Winstrol l; 17beta-Hydroxy-17-METHYL-5ALPHA-androstano[3,2-c]pyrazole |  | C21H32N2O | 詳情 | 供應(yīng)商 |
| 501948-05-6 | 羅沙布林; 3-[(4-氰基苯基)甲基]-N-(3-甲基-5-異噻唑基)-ALPHA-氧代-1-中氮茚乙酰胺 | Rosabulin; 3-[(4-Cyanophenyl)methyl]-N-(3-METHYL-5-isothiazolyl)-ALPHA-oxo-1-indolizineacetamide |  | C22H16N4O2S | 詳情 | 供應(yīng)商 |
| 38049-26-2 | (1Α ,2β,5Α )-2-甲基-5-(1-甲基乙烯基)-環(huán)己烷-1-醇 | (1 .ALPHA., 2 .beta., 5 .ALPHA.)-2-METHYL-5-(1-methylvinyl) cyclohexan-1-ol; Cyclohexanol,2-METHYL-5-(1-methylethenyl)-, (1a,2b,5a)-; (?à)-trans-Dihydrocarveol; Carveol, dihydro-; Cyclohexanol,2-METHYL-5-(1-methylethenyl)-, (1a,2b,5a)-(?à)-; Dihydrocarveol; p-Menth-8-en-2-ol |  | C10H18O | 詳情 | 供應(yīng)商 |
| 77-42-9 | [1S-[1α,2A(Z),4α]]-2-甲基5-(2-甲基-3-次甲基二環(huán)[2.2.1]庚-2-基)-2-戊烯-1-醇 | 2-METHYL-5-(2-methyl-3-methylenebicyclo[2.2.1]hept-2-yl)-, [1S-[1.ALPHA., 2.ALPHA.(Z),4.ALPHA.]]-2-P; 2-Penten-1-ol,2-METHYL-5-(2-methyl-3-methylene-2-norbornyl)- (7CI,8CI); 2-Penten-1-ol,2-METHYL-5-(2-methyl-3-methylenebicyclo[2.2.1]hept-2-yl)-, [1S-[1a,2a(Z),4a]]-; b-Santalol (6CI); (-)-(Z)-b-Santalol; (-)-b-Santalol; Santalol b; cis-b-Santalol |  | C15H24O | 詳情 | 供應(yīng)商 |
| 73003-91-5 | [3S-(3Α ,5Α ,8Α )]-1-甲基-1-(1,2,3,4,5,6,7,8-八氫化-3,8-二甲基-5-奧基)乙醇丁酸酯 | 1-methyl-1-(1,2,3, 4,5, 6, 7,8-octahydro-3,8-diMETHYL-5-azulenyl)ethyl ester, [3S-(3.ALPHA.,5.ALPHAB; Butanoicacid, 1-methyl-1-(1,2,3,4,5,6,7,8-octahydro-3,8-diMETHYL-5-azulenyl)ethylester, [3S-(3a,5a,8a)]- |  | C19H32O2 | 詳情 | 供應(yīng)商 |
| 489-86-1 | [3S-(3Α ,5Α ,8Α )]-1,2,3,4,5,6,7,8-八氫化-Α ,Α -3,8-四甲基-5-奧甲醇 | [3S-(3.ALPHA.,5.ALPHA.,8.ALPHA.)]-1,2,3,4,5,6,7,8-octahydro-.ALPHA.,.ALPHA.-3,8-tetraMETHYL-5-azulen; (-)-guaiol; L-rel-Guai-1(5)-en-11-ol; Gualol |  | C15H26O | 詳情 | 供應(yīng)商 |
| 73003-40-4 | 1,2,3,3A,4,5,6,7(或1,2,3,4,5,6,7,8)-八氫化-Α ,Α -3,8-四甲基奧-5-甲醇 | 1,2,3,3a,4,5,6,7(or 1,2,3, 4,5, 6, 7,8)-octahydro-.ALPHA.,.ALPHA.-3,8-tetraMETHYL-5-Azulenemethanol; Guaiol |  | C15H26O | 詳情 | 供應(yīng)商 |
| 9014-85-1 | Α ,Α '-[1,4-二甲基-1,4-雙(2-甲基丙基-2-丁炔-1,4-二基]雙[ω-羥基-聚(氧基-1,2-亞乙基) | 2-ethanediyl), .ALPHA.,.ALPHA.'-[1,4-dimethyl-1,4-bis(2-methylpropyl)-2-butyne-1,4-diyl]bis[.omega.P; Ethoxylated-2,4,7,9-tetraMETHYL-5-decyne-4,7-diol; poly(oxy-1,2-ethanediyl), ALPHA, ALPHA'-[1,4-dimethyl-1,4-bis(2-methylpropyl)-2; 4-diyl]bis[ omega -hydroxy--butyne- |  | (C2H4O)n(C2H4O)nC14H26O2 | 詳情 | 供應(yīng)商 |
| 93892-05-8 | Butanoic acid,3-methyl-, 2-METHYL-5-(1-methylethenyl)cyclohexyl ester, (1a,2b,5a)- (9CI); (1ALPHA,2beta,5ALPHA)-5-isopropenyl-2-methylcyclohexyl isovalerate |  | C15H26O2 | 詳情 | 供應(yīng)商 | |
| 71662-22-1 | Cyclohexanol,2-METHYL-5-(1-methylethenyl)-, propanoate, (1a,2b,5a)- (9CI); (1ALPHA,2beta,5ALPHA)-2-METHYL-5-(1-methylvinyl)cyclohexyl propionate |  | C13H22O2 | 詳情 | 供應(yīng)商 | |
| 177569-92-5 | Cyclopentanecarboxaldehyde,2-METHYL-5-(1-methylethenyl)-, (1a,2a,5a)- (9CI); Cyclopentanecarboxaldehyde, 2-METHYL-5-(1-methylethenyl)-, (1ALPHA,2ALPHA,5ALPHA)- (9CI) |  | C10H16O | 詳情 | 供應(yīng)商 | |
| 164525-38-6 | Cyclopentanol,1,2-diMETHYL-5-(1-methylethyl)-, (1a,2b,5a)- (9CI); Cyclopentanol, 1,2-diMETHYL-5-(1-methylethyl)-, (1ALPHA,2b閠a,5ALPHA)- (9CI); Cyclopentanol,1,2-diMETHYL-5-(1-methylethyl)-,(1ALPHA,2bta,5ALPHA)-(9CI) |  | C10H20O | 詳情 | 供應(yīng)商 | |
| 964-52-3 | 莫西賽利鹽酸鹽; 4-(2-二甲氨基乙氧基)-5-異丙基-2-甲基酯鹽酸鹽 | Phenol,4-[2-(dimethylamino)ethoxy]-2-METHYL-5-(1-methylethyl)-, 1-acetate,hydrochloride (1:1); Carvacrol,5-[2-(dimethylamino)ethoxy]-, acetate (ester), hydrochloride (8CI); Carvacrol,5-[2-(dimethylamino)ethoxy]-, acetate, hydrochloride (6CI,7CI); Phenol,4-[2-(dimethylamino)ethoxy]-2-METHYL-5-(1-methylethyl)-, acetate (ester),hydrochloride (9CI); 4-(2-Dimethylaminoethoxy)-5-isopropyl-2-methylphenyl acetatehydrochloride; Arlitine; Carlytene; M 101; M 101 (vasodilator); Moxisylytehydrochloride; Moxyl; Opilon; Opilon hydrochloride; Thymoxamine hydrochloride; UroALPHA; Vasoklin |  | C16H26ClNO3 | 詳情 | 供應(yīng)商 |
| 312624-05-8 | 2,6-二[(4R,5R)-4-甲基-5-苯基-2-二惡唑啉]吡啶 | Pyridine,2,6-bis[(4R,5R)-4,5-dihydro-4-METHYL-5-phenyl-2-oxazolyl]-; 2 6-BIS[(4R 5R)-4-METHYL-5-PHENYL-2-OXA&; (4R-(2(4R ,5R ),4ALPHA,5BETA))-2,6-BIS-( DI-H-ME-PH-2-OXAZOLYL)PYRIDINE, 97%; 2,6-bis[(4r,5r)-4,5-dihydro-4-METHYL-5-phenyl-2-oxazolyl]pyridine; 2,6-bis[(4r,5r)-4-METHYL-5-phenyl-2-oxazolinyl]pyridine |  | C25H23N3O2 | 詳情 | 供應(yīng)商 |
| 114482-44-9 | 1,2,2a,3a-Tetrahydro-4-METHYL-5-nitrochryseno(3,4-b)oxirene-1,2-diol (1ALPHA,2beta,2abeta,3abeta)- |  | C19H15NO5 | 詳情 | 供應(yīng)商 | |